Rapid progress in identifying biomarkers that are hallmarks of disease has increased
demand for high-performance detection technologies. Implementation of electrochemical …

The early detection of cancer can significantly reduce cancer mortality and saves lives. Thus,
a great deal of effort has been devoted to the exploration of new technologies to detect early …

Noncoding small RNAs, such as microRNAs, are becoming the biomarkers of choice for
multiple diseases in clinical diagnostics. A dysregulation of these microRNAs can be …

MicroRNA exhibits differential expression levels in cancer and can affect cellular
transformation, carcinogenesis and metastasis. Although fluorescence techniques using dye …

Taking advantage of exceptional attributes, such as being easy-to-operate, economical,
sensitive, portable, and simple-to-construct, in recent decades, considerable attention has …

IVD test is a crucial component of clinical care that performs a diagnostic test on biological
samples that have been taken from a living body, such as blood, urine, and tissue.(1) Such …

Abstract Point-of-care (POC) diagnostic devices are integral in the health care system and
particularly for the diagnosis and monitoring of diseases. POC testing has a variety of …

In the pursuit of improved diagnostic tests for infectious diseases, several classes of
molecules have been scrutinized as prospective biomarkers. Small (18–22 nucleotide), non …

Cancer is a dreadful disease with a high mortality rate, and it has become more and more
prevalent worldwide. Early diagnosis, prognosis and treatment monitoring with robust and …

As being the most extensively studied, non-coding, evolutionary conserved, post-
transcriptional gene regulators of genome, microRNAs (miRNAs) have taken great attention …